Clinical Trial

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 12, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This research study aims to address the limited understanding of the challenges faced by specific demographic groups of chronic lymphocytic leukemia patients in their participation in clinical trials. This trial will scrutinize the experiences of patients diagnosed with chronic lymphocytic leukemia as they take part in a separate medical intervention clinical trial. The focus will be on tracking the rates of completion and withdrawal among these individuals. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chronic lymphocytic leukemia patients.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05899543
Lead Sponsor Power Life Sciences Inc.
Conditions Chronic Lymphocytic Leukemia
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-06-12